Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects

Clinical trial NCT05905068 · COMPLETED

Trial details

NCT number: NCT05905068
Sponsor: Ikaria Bioscience Pty Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

To Reduce the LDL-C Level in Hypercholesteremia Adult Patients Combination for Subgroup High LDL-c Patients With Other Comorbidities

Start date: 2023-07-14
Primary completion: 2024-02-24
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.